A Study of AK-1286 in Patients With Advanced Solid Tumors

Clinical trial NCT06779045 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06779045
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-02-01
Primary completion: 2026-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.